BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12538879)

  • 1. Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model.
    Kannan K; Sharpless NE; Xu J; O'Hagan RC; Bosenberg M; Chin L
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1221-5. PubMed ID: 12538879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The INK4a/ARF locus and melanoma.
    Sharpless E; Chin L
    Oncogene; 2003 May; 22(20):3092-8. PubMed ID: 12789286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
    Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma.
    O'Hagan RC; Brennan CW; Strahs A; Zhang X; Kannan K; Donovan M; Cauwels C; Sharpless NE; Wong WH; Chin L
    Cancer Res; 2003 Sep; 63(17):5352-6. PubMed ID: 14500367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic dissection of melanoma pathways in the mouse.
    Yang FC; Merlino G; Chin L
    Semin Cancer Biol; 2001 Jun; 11(3):261-8. PubMed ID: 11407950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.
    Sharpless NE; Kannan K; Xu J; Bosenberg MW; Chin L
    Oncogene; 2003 Aug; 22(32):5055-9. PubMed ID: 12902988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired processing of DNA photoproducts and ultraviolet hypermutability with loss of p16INK4a or p19ARF.
    Sarkar-Agrawal P; Vergilis I; Sharpless NE; DePinho RA; RĂ¼nger TM
    J Natl Cancer Inst; 2004 Dec; 96(23):1790-3. PubMed ID: 15572761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.
    Recio JA; Noonan FP; Takayama H; Anver MR; Duray P; Rush WL; Lindner G; De Fabo EC; DePinho RA; Merlino G
    Cancer Res; 2002 Nov; 62(22):6724-30. PubMed ID: 12438273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genes involved in melanoma: an overview of INK4a and other loci.
    Castellano M; Parmiani G
    Melanoma Res; 1999 Oct; 9(5):421-32. PubMed ID: 10596908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.
    Becker TM; Rizos H; Kefford RF; Mann GJ
    Clin Cancer Res; 2001 Oct; 7(10):3282-8. PubMed ID: 11595726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
    Easton J; Wei T; Lahti JM; Kidd VJ
    Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.
    van Schanke A; van Venrooij GM; Jongsma MJ; Banus HA; Mullenders LH; van Kranen HJ; de Gruijl FR
    Cancer Res; 2006 Mar; 66(5):2608-15. PubMed ID: 16510579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis.
    Ferguson B; Konrad Muller H; Handoko HY; Khosrotehrani K; Beermann F; Hacker E; Soyer HP; Bosenberg M; Walker GJ
    Pigment Cell Melanoma Res; 2010 Dec; 23(6):771-80. PubMed ID: 20718941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation.
    Al-Khalaf HH; Hendrayani SF; Aboussekhra A
    Mol Cancer Res; 2011 Mar; 9(3):311-9. PubMed ID: 21270107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.